Bio-Based Polymers Towards Net Zero In Single-Use Bioprocessing
By Karl Britt, VP of Technology and Eco-Design, Cytiva
It is broadly recognized that achieving global climate goals hinges on the substantial decarbonization of industrial sectors. Without decisive and immediate action, the world risks surpassing the critical threshold of a 1.5°C rise in global temperatures—a limit scientists agree is essential to avoid the most catastrophic impacts of climate change. Each sector of industry faces its own distinct set of challenges in this transition, and the healthcare sector, along with its extensive network of suppliers, including the pharmaceutical industry, is no exception. These industries are not only energy-intensive but also deeply embedded in complex global supply chains, which makes their path to sustainability particularly intricate. Nonetheless, their role is pivotal.
Learn why reducing emissions in healthcare and pharmaceuticals is essential not only for environmental reasons but also to protect public health from the escalating threats posed by a warming planet.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Biosimilar Development? Subscribe today.